December 23, 2020 -- Twist Bioscience plans to offer a new synthetic RNA control that includes the new variant of SARS-CoV-2 circulating in the U.K. and South Africa.
The newly identified strain of the virus contains multiple spike protein mutations, as well as mutations in other areas of the viral genome, and may increase SARS-CoV-2 transmissibility by up to 70%.
Twist said it expects the new control to be available by January 15, 2021.
Already have an account? Sign in Here
To access all ScienceBoard content create a free account now: